Our R&D technology platform

Cerelixis has developed a pipeline of small molecules with the potential to improve crop productivity. Our approach applies EMBL proprietary high-throughput screening technology to develop precision chemicals targeting specific proteins.

We start with a well-characterized biological target and screen a large number of small molecules against this target. The benefit is that we can rapidly identify multiple small molecules that bind to the biological target and serve as a starting point for rational drug design that we can rapidly optimize to high-value assets.